首页> Alzheimer's & dementia : the journal of the Alzheimer's Association> ADNI Biomarker Core: A review of progress since 2004 and future challenges.

ADNI Biomarker Core: A review of progress since 2004 and future challenges.

导出 OA

翻译打印收藏纠错

第一作者： Leslie M,Shaw

第一单位： Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

作者： Leslie M,Shaw ^[1] ; Magdalena,Korecka ^[1] ; Edward B,Lee ^[1] ; Katheryn A Q,Cousins ^[2] ; Hugo,Vanderstichele ^[3] ; Suzanne E,Schindler ^[4] ; Duygu,Tosun ^[5] ; Mari L,DeMarco ^[6] ; Magdalena,Brylska ^[1] ; Yang,Wan ^[1] ; Samantha,Burnham ^[7] ; Alexandria,Sciulli ^[1] ; Amberley,Vulaj ^[1] ; Thomas F,Tropea ^[2] ; Alice,Chen-Plotkin ^[2] ; David A,Wolk ^[2] ; Alzheimer's Disease Neuroimaging Initiative

作者单位： Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA. ^[1] Neurology Department, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA. ^[2] Biomarkable bv, Tuinwijklaan, Belgium, Belgium. ^[3] Knight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, Missouri, USA. ^[4] Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California, USA. ^[5] Department of Pathology and Laboratory Medicine, University of British Columbia, Van Couver, Canada. ^[6] Department of AVID, Eli Lilly and Company, Indianapolis, Indiana, USA. ^[7]

关键词 Alzheimer's disease amyloid PET biomarkers cerebrospinal fluid neuropathologic diagnosis plasma pre‐analytical

医学主题词人类(Humans);阿尔茨海默病(Alzheimer Disease);生物标本库(Biological Specimen Banks);疾病恶化(Disease Progression);质谱分析法(Mass Spectrometry)

DOI 10.1002/alz.14264

PMID 39614747

发布时间 2026-05-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交